Miragen Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Miragen Therapeutics (VRDN) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Miragen Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Miragen Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Miragen Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $9.1M | 400k | 22.75 |
| 2024-06-30 | $1.6M | 126k | 13.01 |
| 2024-03-31 | $858k | 49k | 17.51 |
| 2023-12-31 | $1.2M | 57k | 21.78 |
| 2023-09-30 | $781k | 51k | 15.34 |
| 2023-06-30 | $1.4M | 60k | 23.79 |
| 2023-03-31 | $1.3M | 49k | 25.44 |
| 2022-12-31 | $5.0M | 172k | 29.21 |
| 2022-06-30 | $213k | 18k | 11.63 |
| 2022-03-31 | $345k | 19k | 18.48 |
| 2021-12-31 | $258k | 13k | 19.80 |
| 2021-03-31 | $0 | 10 | 0.00 |